FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2494579016> ?p ?o ?g. }

• W2494579016 endingPage "1118" @default.
• W2494579016 startingPage "1109" @default.
• W2494579016 abstract "•We estimate 62.6 million statin-eligible US adults from NHANES 2011-2012 subjects. •Statin use varied from 27% (≥7.5% risk) to 64% (ASCVD) by statin-eligible group. •Across statin-eligible groups, between 71% and 99% were not at LDL-C goal. •Adherence to recommended <6% calories from saturated fat ranged from 3% to 6%. •Those with greater than or equal to 40 minutes of physical activity 3 or more times a week ranged from 55% to 65%. Background The 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline identifies 4 statin-eligible groups: (1) known atherosclerotic cardiovascular disease (ASCVD) aged ≥21 years, (2) low-density lipoprotein cholesterol (LDL-C) ≥ 190 mg/dL (4.9 mmol/L) aged ≥21 years, (3) diabetes mellitus aged 40 to 75 years with LDL-C 70 to 189 mg/dL (1.8–4.9 mmol/L), or (4) ≥7.5% 10-year ASCVD risk aged 40 to 75 years with LDL-C 70 to 189 mg/dL (1.8–4.9 mmol/L). Objectives We examined the number of statin-eligible US adults, statin use, LDL-C goal attainment, and adherence to lifestyle management. Methods We identified subjects from the US National Health and Nutrition Examination Survey 2011–2012 in the 4 statin-eligible groups, proportion on statin, proportion at recommended LDL-C levels using National Lipid Association goals (<70 mg/dL [1.8 mmol/L] for very high risk and <100 mg/dL [2.6 mmol/L] for others), and adherence to lifestyle measures. Results Of 5206 adults (representing 219 million), 1677 adults representing 62.6 million adults fit into 1 of the 4 statin-eligible groups. Statin use was 63.7% for the ASCVD, 61.4% for the LDL-C ≥ 190 mg/dL (4.9 mmol/L), 43.2% for the diabetes mellitus, and 27.2% for the 10-year risk ≥7.5% groups. Of those on statins with LDL-C measured, 79.7%, 98.0%, 42.3%, and 46.8% were not at LDL-C goal. Adherence to recommended <6% calories from saturated fat ranged from 3.3% to 6.4% and ≥40 minutes of physical activity ≥3 times a week from 54.7% to 65.1% across statin-eligible groups. Conclusion Many US adults eligible to receive statins based on American College of Cardiology/American Heart Association guidelines are not taking statins, and LDL-C levels still remain suboptimal. The 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline identifies 4 statin-eligible groups: (1) known atherosclerotic cardiovascular disease (ASCVD) aged ≥21 years, (2) low-density lipoprotein cholesterol (LDL-C) ≥ 190 mg/dL (4.9 mmol/L) aged ≥21 years, (3) diabetes mellitus aged 40 to 75 years with LDL-C 70 to 189 mg/dL (1.8–4.9 mmol/L), or (4) ≥7.5% 10-year ASCVD risk aged 40 to 75 years with LDL-C 70 to 189 mg/dL (1.8–4.9 mmol/L). We examined the number of statin-eligible US adults, statin use, LDL-C goal attainment, and adherence to lifestyle management. We identified subjects from the US National Health and Nutrition Examination Survey 2011–2012 in the 4 statin-eligible groups, proportion on statin, proportion at recommended LDL-C levels using National Lipid Association goals (<70 mg/dL [1.8 mmol/L] for very high risk and <100 mg/dL [2.6 mmol/L] for others), and adherence to lifestyle measures. Of 5206 adults (representing 219 million), 1677 adults representing 62.6 million adults fit into 1 of the 4 statin-eligible groups. Statin use was 63.7% for the ASCVD, 61.4% for the LDL-C ≥ 190 mg/dL (4.9 mmol/L), 43.2% for the diabetes mellitus, and 27.2% for the 10-year risk ≥7.5% groups. Of those on statins with LDL-C measured, 79.7%, 98.0%, 42.3%, and 46.8% were not at LDL-C goal. Adherence to recommended <6% calories from saturated fat ranged from 3.3% to 6.4% and ≥40 minutes of physical activity ≥3 times a week from 54.7% to 65.1% across statin-eligible groups. Many US adults eligible to receive statins based on American College of Cardiology/American Heart Association guidelines are not taking statins, and LDL-C levels still remain suboptimal." @default.
• W2494579016 created "2016-08-23" @default.
• W2494579016 creator A5002862446 @default.
• W2494579016 creator A5009954277 @default.
• W2494579016 creator A5041359666 @default.
• W2494579016 creator A5044764752 @default.
• W2494579016 creator A5075397090 @default.
• W2494579016 creator A5086073841 @default.
• W2494579016 creator A5091839496 @default.
• W2494579016 date "2016-09-01" @default.
• W2494579016 modified "2023-10-06" @default.
• W2494579016 title "Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012" @default.
• W2494579016 cites W1709407542 @default.
• W2494579016 cites W1883027722 @default.
• W2494579016 cites W2007221722 @default.
• W2494579016 cites W2013818621 @default.
• W2494579016 cites W2016814912 @default.
• W2494579016 cites W2038595819 @default.
• W2494579016 cites W2051160165 @default.
• W2494579016 cites W2082336558 @default.
• W2494579016 cites W2097092357 @default.
• W2494579016 cites W2097870088 @default.
• W2494579016 cites W2118184073 @default.
• W2494579016 cites W2121568629 @default.
• W2494579016 cites W2123124749 @default.
• W2494579016 cites W2137959339 @default.
• W2494579016 cites W2142164422 @default.
• W2494579016 cites W2145839043 @default.
• W2494579016 cites W2153205212 @default.
• W2494579016 cites W2155965977 @default.
• W2494579016 cites W2160812379 @default.
• W2494579016 cites W2164089346 @default.
• W2494579016 cites W2168536722 @default.
• W2494579016 cites W2319057797 @default.
• W2494579016 cites W2911328847 @default.
• W2494579016 cites W4236673002 @default.
• W2494579016 cites W52391516 @default.
• W2494579016 doi "https://doi.org/10.1016/j.jacl.2016.06.011" @default.
• W2494579016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27678427" @default.
• W2494579016 hasPublicationYear "2016" @default.
• W2494579016 type Work @default.
• W2494579016 sameAs 2494579016 @default.
• W2494579016 citedByCount "57" @default.
• W2494579016 countsByYear W24945790162016 @default.
• W2494579016 countsByYear W24945790162017 @default.
• W2494579016 countsByYear W24945790162018 @default.
• W2494579016 countsByYear W24945790162019 @default.
• W2494579016 countsByYear W24945790162020 @default.
• W2494579016 countsByYear W24945790162021 @default.
• W2494579016 countsByYear W24945790162022 @default.
• W2494579016 countsByYear W24945790162023 @default.
• W2494579016 crossrefType "journal-article" @default.
• W2494579016 hasAuthorship W2494579016A5002862446 @default.
• W2494579016 hasAuthorship W2494579016A5009954277 @default.
• W2494579016 hasAuthorship W2494579016A5041359666 @default.
• W2494579016 hasAuthorship W2494579016A5044764752 @default.
• W2494579016 hasAuthorship W2494579016A5075397090 @default.
• W2494579016 hasAuthorship W2494579016A5086073841 @default.
• W2494579016 hasAuthorship W2494579016A5091839496 @default.
• W2494579016 hasConcept C126322002 @default.
• W2494579016 hasConcept C134018914 @default.
• W2494579016 hasConcept C142724271 @default.
• W2494579016 hasConcept C1862650 @default.
• W2494579016 hasConcept C2776839432 @default.
• W2494579016 hasConcept C2778163477 @default.
• W2494579016 hasConcept C2778402494 @default.
• W2494579016 hasConcept C2779874844 @default.
• W2494579016 hasConcept C2780182762 @default.
• W2494579016 hasConcept C2780578515 @default.
• W2494579016 hasConcept C2908647359 @default.
• W2494579016 hasConcept C555293320 @default.
• W2494579016 hasConcept C71924100 @default.
• W2494579016 hasConcept C99454951 @default.
• W2494579016 hasConceptScore W2494579016C126322002 @default.
• W2494579016 hasConceptScore W2494579016C134018914 @default.
• W2494579016 hasConceptScore W2494579016C142724271 @default.
• W2494579016 hasConceptScore W2494579016C1862650 @default.
• W2494579016 hasConceptScore W2494579016C2776839432 @default.
• W2494579016 hasConceptScore W2494579016C2778163477 @default.
• W2494579016 hasConceptScore W2494579016C2778402494 @default.
• W2494579016 hasConceptScore W2494579016C2779874844 @default.
• W2494579016 hasConceptScore W2494579016C2780182762 @default.
• W2494579016 hasConceptScore W2494579016C2780578515 @default.
• W2494579016 hasConceptScore W2494579016C2908647359 @default.
• W2494579016 hasConceptScore W2494579016C555293320 @default.
• W2494579016 hasConceptScore W2494579016C71924100 @default.
• W2494579016 hasConceptScore W2494579016C99454951 @default.
• W2494579016 hasFunder F4320311600 @default.
• W2494579016 hasIssue "5" @default.
• W2494579016 hasLocation W24945790161 @default.
• W2494579016 hasLocation W24945790162 @default.
• W2494579016 hasOpenAccess W2494579016 @default.
• W2494579016 hasPrimaryLocation W24945790161 @default.
• W2494579016 hasRelatedWork W158308617 @default.
• W2494579016 hasRelatedWork W1975748249 @default.
• W2494579016 hasRelatedWork W2085533832 @default.
• W2494579016 hasRelatedWork W2100289151 @default.
• W2494579016 hasRelatedWork W2133667648 @default.

• next